The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients

Untapped potential of health impact assessment

(2013) Mirko S Winkler et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Health Services Utilization and Cost of Retinitis Pigmentosa

(2012) Kevin D. Frick et al.   ARCHIVES OF OPHTHALMOLOGY

Interim Results from the International Trial of Second Sight's Visual Prosthesis

(2012) Mark S. Humayun et al.   OPHTHALMOLOGY

The Contribution of Health Technology Assessment, Health Needs Assessment, and Health Impact Assessment to the Assessment and Translation of Technologies in the Field of Public Health Genomics

(2010) N. Rosenkötter et al.   Public Health Genomics

Health Economic Assessment: Cost-Effectiveness Thresholds and Other Decision Criteria

(2010) Steven Simoens   International Journal of Environmental Research and Public Health

Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration

(2009) Luis Javier Hernández-Pastor et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Age at Onset Curves of Retinitis Pigmentosa

(2008) Motokazu Tsujikawa   ARCHIVES OF OPHTHALMOLOGY

Depression and the vision-related quality of life in patients with retinitis pigmentosa

(2008) B-J Hahm et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold

(2008) Scott D Grosse   Expert Review of Pharmacoeconomics & Outcomes Research